Cancer Causes & Control is an international refereed journal that both reports and stimulates new avenues of investigation into the causes, control, and subsequent prevention of cancer. By drawing together related information published currently in a diverse range of biological and medical journals, it has a multidisciplinary and multinational approach.

The scope of the journal includes: variation in cancer distribution within and between populations; factors associated with cancer risk; preventive and therapeutic interventions on a population scale; economic, demographic, and health-policy implications of cancer; and related methodological issues.

The emphasis is on speed of publication. The journal will normally publish within 30 to 60 days of acceptance of manuscripts.

Cancer Causes & Control publishes Original Articles, Reviews, Commentaries, Opinions, Short Communications and Letters to the Editor which will have direct relevance to researchers and practitioners working in epidemiology, medical statistics, cancer biology, health education, medical economics and related fields. The journal also contains significant information for government agencies concerned with cancer research, control and policy.

Editor-in-Chief:
Immaculata De Vivo
Harvard Medical School, Boston, MA, USA
Editor Emeritus:
Graham A. Colditz
Channing Laboratory, Harvard University, Boston, MA, USA
Edward Giovannucci
Harvard School of Public Health, Boston, MA, USA
Associate Editors:
Madina Agenor, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Kimberly Bertrand, Slone Epidemiology Center, Boston University; Theodore Brasky, The Ohio State University, College of Medicine, Columbus, USA; Brenda Birmann, Harvard Medical School, Boston, MA, USA; Jennifer E. Cameron, Ohio State University Health Sciences Library, New Orleans, LA, USA ; Marta Crous Bou, Barcelona Beta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Eunyoung Cho, Alpert Medical School, Brown University, Providence, RI, USA; Graham A. Colditz, Washington University School of Medicine, St. Louis, MO, USA; Mengmeng Du, Memorial Sloane Kettering Cancer Center, New York, NY, USA; Heather Eliassen, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Jiali Han, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA; Jamie Hart, Harvard School of Public Health, Boston, MA, USA; Corinne Joshu, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Seungyoun Jung, University of Maryland School of Medicine, Baltimore, MD, USA; Elizabeth Kantor, Memorial Sloane Kettering Cancer Center, New York, NY, USA; Jaya Shankar Khushalani, Centers for Disease Control and Prevention, Atlanta, GA, USA ; Pagona Lagiou,University of Athens Medical School, Athens, Greece; Michael Leitzmann, Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany; Faina Linkov, Magee-Women's Research Institute, Pittsburgh, PA, USA; Dominique Michaud, Tufts University School of Medicine, Boston, MA, USA; Alison Mondul, University of Michigan, MI, USA; Beth A. Mueller, Department of Epidemiology,University of Washington, Seattle, WA, USA; Hongmei Nan, Indiana University, Indianapolis, IN, USA; Jenny N. Poynter, Division of Epidemiology and Clinical Research, University of Minnesota Medical School, Minneapolis, MN, USA; Camille Ragin, Fox Chase Cancer Center, Philadelphia, PA, USA; Jennifer R. Rider, Boston University School of Public Health, Boston, MA USA; Sabine Rohrmann, University of Zurich, Zürich, Switzerland; Eva Schernhammer, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; V. Wendy Setiawan, University of Southern California, Los Angeles, CA, USA; Lisa Signorello, National Cancer Institute, Bethesda, MD, USA; Siobhan Sutcliffe, Washington University School of Medicine, St. Louis, MO, USA; Kathryn Terry, Brigham and Women's Hospital, Boston, MA, USA; Britton Trabert, National Cancer Institute, Bethesda, MD, USA; Shelley Tworoger, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA;
Editorial Board:
Hans-Olav Adami, Karolinska Institute, Stockholm, Sweden; Peter Boyle, European Institute of Oncology, Milan, Italy; Jo L. Freudenheim, University at Buffalo, NY, USA; Christine Friedenreich, Alberta Cancer Board, Calgary, Canada; Adèle Green, Queensland Institute of Medical Research, Brisbane, Australia; Richard B. Hayes, Division of Epidemiology, NYU Medical Center, New York, NY, USA; Robert A. Hiatt, UCSF Comprehensive Cancer Center, University of California at San Francisco, USA; T.J.A. Key, ICRF Cancer Epidemiology Unit, University of Oxford, UK; Elsebeth Lynge, Danish Cancer Society, Copenhagen, Denmark; Jing Ma, Brigham & Women's Hospital, Boston MA, USA; Mads Melbye, Statens Serum Institut, Copenhagen, Denmark; Steven Narod, The Centre for Research in Women's Health, Toronto, ON, Canada; Andrew F. Olshan, University of North Carolina at Chapel Hill, USA; Neil Pearce, Wellington School of Medicine, New Zealand; Barbara K. Rimer, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, USA; Leslie L. Robison, St. Jude Children's Research Hospital, Memphis,TN, USA; Lynn Rosenberg, Boston University, MA, USA; Annie J. Sasco, Bordeaux Segalen University, Bordeaux, France; Adeline Seow, The National University of Singapore; Hans H. Storm, Danish Cancer Society, Copenhagen, Denmark; Kazuo Tajima, Aichi Cancer Center Research Institute, Nagoya, Japan; Rebecca Troisi, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA; Anna H. Wu, University of Southern California, Los Angeles, USA; Shelia H. Zahm, National Cancer Institute, Rockville, MD, USA